Argenx Se ARGX
NASDAQ ARGX
$929.07 +34.30 (+3.83%)
As of: Nov 6, 2026 · 3:59 PM EST

Argenx Se (ARGX) Non-Current Deferred Revenue (2016 - 2020)

Updated

Analysis

Argenx Se (ARGX) Non-Current Deferred Revenue (2016 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn
10 Argenx Se 56.96 Bn 56.96 Bn 1.56 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 269.67 Bn
Jun 30, 2020 227.82 Mn
Dec 31, 2019 244.25 Mn
Jun 30, 2019 270.30 Mn
Dec 31, 2017 1.71 Mn
Dec 31, 2016 10.65 Mn
API Access

Argenx Se Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ARGX&period=max&api_key=YOUR_API_KEY